Jiangsu Kanion Pharmaceutical Co Ltd (600557) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥201.83 Million ≈ $29.53 Million USD) by net assets (CN¥4.91 Billion ≈ $718.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600557 market cap for the company's overall valuation and market capitalisation.
Jiangsu Kanion Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Jiangsu Kanion Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiangsu Kanion Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Kanion Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Jiangsu Kanion Pharmaceutical Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STAAR Surgical Company
NASDAQ:STAA
|
0.054x |
|
Baltic Classifieds Group PLC
LSE:BCG
|
0.103x |
|
Zhejiang Hongchang Electrical Technology Co. Ltd.
SHE:301008
|
0.052x |
|
Coretronic
TWO:5371
|
-0.004x |
|
Hangzhou MDK Opto Electronic Corp. Ltd. A
SHG:688079
|
0.015x |
|
Dividend 15 Split Corp
TO:DFN
|
0.024x |
|
NATURENERGIE
SW:NEAG
|
0.173x |
|
Piedmont Office Realty Trust Inc
NYSE:PDM
|
0.040x |
Annual Cash Flow Conversion Efficiency for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. View today's stock price for Jiangsu Kanion Pharmaceutical Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.71 Billion ≈ $688.50 Million |
CN¥702.49 Million ≈ $102.80 Million |
0.149x | -17.38% |
| 2023-12-31 | CN¥5.38 Billion ≈ $787.34 Million |
CN¥972.32 Million ≈ $142.28 Million |
0.181x | -10.47% |
| 2022-12-31 | CN¥4.93 Billion ≈ $722.00 Million |
CN¥995.94 Million ≈ $145.74 Million |
0.202x | -0.60% |
| 2021-12-31 | CN¥4.47 Billion ≈ $654.50 Million |
CN¥908.30 Million ≈ $132.91 Million |
0.203x | +25.32% |
| 2020-12-31 | CN¥4.33 Billion ≈ $633.14 Million |
CN¥701.10 Million ≈ $102.59 Million |
0.162x | -28.45% |
| 2019-12-31 | CN¥4.09 Billion ≈ $598.12 Million |
CN¥925.73 Million ≈ $135.46 Million |
0.226x | +38.52% |
| 2018-12-31 | CN¥3.89 Billion ≈ $569.56 Million |
CN¥636.39 Million ≈ $93.12 Million |
0.164x | +53.44% |
| 2017-12-31 | CN¥3.59 Billion ≈ $525.84 Million |
CN¥382.93 Million ≈ $56.03 Million |
0.107x | +14.25% |
| 2016-12-31 | CN¥3.21 Billion ≈ $469.11 Million |
CN¥299.02 Million ≈ $43.76 Million |
0.093x | -47.99% |
| 2015-12-31 | CN¥2.87 Billion ≈ $420.08 Million |
CN¥514.80 Million ≈ $75.33 Million |
0.179x | +47.14% |
| 2014-12-31 | CN¥2.56 Billion ≈ $374.06 Million |
CN¥311.54 Million ≈ $45.59 Million |
0.122x | -39.25% |
| 2013-12-31 | CN¥1.93 Billion ≈ $283.08 Million |
CN¥388.11 Million ≈ $56.79 Million |
0.201x | +56.12% |
| 2012-12-31 | CN¥1.65 Billion ≈ $241.54 Million |
CN¥212.11 Million ≈ $31.04 Million |
0.129x | +110.14% |
| 2011-12-31 | CN¥1.47 Billion ≈ $215.81 Million |
CN¥90.19 Million ≈ $13.20 Million |
0.061x | -54.27% |
| 2010-12-31 | CN¥1.24 Billion ≈ $182.08 Million |
CN¥166.40 Million ≈ $24.35 Million |
0.134x | +759.34% |
| 2009-12-31 | CN¥1.08 Billion ≈ $157.77 Million |
CN¥-21.87 Million ≈ $-3.20 Million |
-0.020x | -133.16% |
| 2008-12-31 | CN¥954.72 Million ≈ $139.71 Million |
CN¥58.39 Million ≈ $8.54 Million |
0.061x | -63.20% |
| 2007-12-31 | CN¥557.95 Million ≈ $81.65 Million |
CN¥92.73 Million ≈ $13.57 Million |
0.166x | -24.83% |
| 2006-12-31 | CN¥492.91 Million ≈ $72.13 Million |
CN¥108.98 Million ≈ $15.95 Million |
0.221x | -0.20% |
| 2005-12-31 | CN¥457.89 Million ≈ $67.00 Million |
CN¥101.44 Million ≈ $14.84 Million |
0.222x | +323.09% |
| 2004-12-31 | CN¥414.10 Million ≈ $60.60 Million |
CN¥21.68 Million ≈ $3.17 Million |
0.052x | +14.61% |
| 2003-12-31 | CN¥374.88 Million ≈ $54.86 Million |
CN¥17.13 Million ≈ $2.51 Million |
0.046x | +36.56% |
| 2002-12-31 | CN¥333.38 Million ≈ $48.78 Million |
CN¥11.15 Million ≈ $1.63 Million |
0.033x | -88.24% |
| 2001-12-31 | CN¥73.91 Million ≈ $10.82 Million |
CN¥21.02 Million ≈ $3.08 Million |
0.284x | -- |
About Jiangsu Kanion Pharmaceutical Co Ltd
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 a… Read more